dexmedetomidine has been researched along with Necrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Huang, Y; Li, A; Tailaiti, T; Wang, J; Wu, J; Zou, T | 1 |
| Ergene, S; Hemsinli, D; Karakisi, SO; Mercantepe, T; Tumkaya, L; Yılmaz, A | 1 |
| Acar, M; Erdem, AF; Özdin, M; Sayhan Kaplan, H; Tomak, Y; Turan, G | 1 |
| Fang, M; He, J; Li, W; Lin, D; Ma, X | 1 |
| Bao, HG; Shen, Y; Si, YN; Wang, JS; Wang, XL; Xu, L; Yang, XB | 1 |
| Álvarez, J; Baluja, A; Castillo, J; del Río, SV; López, P; Rodríguez-García, J; Rodríguez-González, R; Sobrino, T; Veiga, S | 1 |
6 other study(ies) available for dexmedetomidine and Necrosis
| Article | Year |
|---|---|
Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis.
Topics: Adenosine Triphosphate; Adrenergic alpha-2 Receptor Agonists; AMP-Activated Protein Kinases; Animals; bcl-2-Associated X Protein; Dexmedetomidine; Interleukin-6; Macrophage Migration-Inhibitory Factors; Mice; Myocardial Reperfusion Injury; Necrosis; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha | 2022 |
Dexmedetomidine alleviates vacuolization and necrosis in tubular epithelial cells induced by aortic cross-clamping.
Topics: Acute Kidney Injury; Animals; Constriction; Dexmedetomidine; Epithelial Cells; Interleukin-6; Kidney; Necrosis; Rats; Reperfusion Injury | 2023 |
Effects of dexmedetomidine on new oxidative stress markers on renal ischaemia-reperfusion injury in rats: thiol/disulphide homeostasis and the ischaemia-modified albumin.
Topics: Animals; Antioxidants; Biomarkers; Dexmedetomidine; Disulfides; Homeostasis; Kidney; Necrosis; Oxidants; Oxidative Stress; Rats; Reperfusion Injury; Serum Albumin; Serum Albumin, Human; Sulfhydryl Compounds | 2022 |
Protective effects of dexmedetomidine on the survival of random flaps.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents; Antioxidants; Dexmedetomidine; Inflammation Mediators; Lipid Peroxidation; Necrosis; Neovascularization, Physiologic; Oxidative Stress; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Surgical Flaps; Tissue Survival; Vascular Endothelial Growth Factor A | 2020 |
Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney.
Topics: Acute-Phase Proteins; Animals; Apoptosis; Biomarkers; Blood Urea Nitrogen; Creatine; Cystatin C; Dexmedetomidine; Janus Kinase 2; Kidney Diseases; Kidney Tubules; Lipocalin-2; Lipocalins; Male; Necrosis; Protective Agents; Proto-Oncogene Proteins; Rats, Wistar; Reperfusion Injury; STAT3 Transcription Factor | 2014 |
Neuroprotective effects of dexmedetomidine conditioning strategies: Evidences from an in vitro model of cerebral ischemia.
Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Dexmedetomidine; In Vitro Techniques; Interleukin-6; Ischemic Postconditioning; Ischemic Preconditioning; Necrosis; Neuroprotective Agents; Organ Culture Techniques; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2016 |